Antidepressant medications and osteoporosis

Antidepressant medications and osteoporosis

Use of antidepressant medications that act on the serotonin system has been linked to detrimental impacts on bone mineral density (BMD), and to osteoporosis. This article reviews current evidence for such effects, and identifies themes for future research. Serotonin receptors are found in all major...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Rizzoli, R, Cooper, C, Reginster, J, Abrahamsen, B, Adachi, J, Brandi, M, Bruyère, O, Compston, J, Ducy, P, Ferrari, S, Harvey, N, Kanis, J, Karsenty, G, Laslop, A, Rabenda, V, Vestergaard, P
التنسيق:	Journal article
منشور في:	2012

مواد مشابهة

Partial adherence: a new perspective on health economic assessment in osteoporosis.
حسب: Kanis, J, وآخرون
منشور في: (2011)

A reappraisal of generic bisphosphonates in osteoporosis.
حسب: Kanis, J, وآخرون
منشور في: (2012)

Management of glucocorticoid-induced osteoporosis.
حسب: Rizzoli, R, وآخرون
منشور في: (2012)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
حسب: Rizzoli, R, وآخرون
منشور في: (2013)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
حسب: Delmas, P, وآخرون
منشور في: (2005)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
حسب: Kanis, J, وآخرون
منشور في: (2008)

Health technology assessment in osteoporosis.
حسب: Hiligsmann, M, وآخرون
منشور في: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
حسب: Kanis, J, وآخرون
منشور في: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
حسب: Kanis, J, وآخرون
منشور في: (2013)

The International Osteoporosis Foundation: history, objectives and achievements.
حسب: Cooper, C, وآخرون
منشور في: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
حسب: Cooper, C, وآخرون
منشور في: (2009)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
حسب: Cooper, C, وآخرون
منشور في: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
حسب: Kanis, J, وآخرون
منشور في: (2008)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
حسب: Rizzoli, R, وآخرون
منشور في: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
حسب: Rizzoli, R, وآخرون
منشور في: (2011)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
حسب: Rizzoli, R, وآخرون
منشور في: (2014)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
حسب: Bruyère, O, وآخرون
منشور في: (2014)

Challenges for the development of bone-forming agents in Europe
حسب: Kanis, J, وآخرون
منشور في: (2014)

Challenges for the development of bone-forming agents in Europe.
حسب: Kanis, J, وآخرون
منشور في: (2014)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
حسب: Harvey, N, وآخرون
منشور في: (2016)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
حسب: Rizzoli, R, وآخرون
منشور في: (2011)

Treatment of osteoporosis in men.
حسب: Kaufman, J, وآخرون
منشور في: (2013)

Modelling cost-effectiveness in osteoporosis
حسب: Kanis, J, وآخرون
منشور في: (2008)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
حسب: Rizzoli, R, وآخرون
منشور في: (2014)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
حسب: Gauthier, A, وآخرون
منشور في: (2009)

The cost-effectiveness of alendronate in the management of osteoporosis.
حسب: Kanis, J, وآخرون
منشور في: (2008)

Assessment of cardiovascular safety of anti-osteoporosis drugs
حسب: Fuggle, NR, وآخرون
منشور في: (2020)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
حسب: Hiligsmann, M, وآخرون
منشور في: (2013)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
حسب: Bruyere, O, وآخرون
منشور في: (2013)

CHANGES IN THE STRUCTURE AND THE SYMPTOMS OF THE OSTEOARTHRITIC KNEE AND PREDICTION OF FUTURE KNEE REPLACEMENT OVER AN 8-YEAR FOLLOW-UP PERIOD
حسب: Bruyere, O, وآخرون
منشور في: (2013)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
حسب: Compston, J, وآخرون
منشور في: (2013)

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art
حسب: Fuggle, NR, وآخرون
منشور في: (2024)

Development and validation of a disease model for postmenopausal osteoporosis.
حسب: Gauthier, A, وآخرون
منشور في: (2011)

Fracture risk following intermission of osteoporosis therapy
حسب: Dennison, EM, وآخرون
منشور في: (2019)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
حسب: Kanis, J, وآخرون
منشور في: (1997)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
حسب: Bruyère, O, وآخرون
منشور في: (2008)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
حسب: Ström, O, وآخرون
منشور في: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
حسب: Gauthier, A, وآخرون
منشور في: (2010)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
حسب: Compston, J, وآخرون
منشور في: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
حسب: Compston, J, وآخرون
منشور في: (2013)